| ATR inhibition potentiates the radiation-induced inflammatory tumor microenvironment MT Dillon, KF Bergerhoff, M Pedersen, H Whittock, E Crespo-Rodriguez, ... Clinical Cancer Research 25 (11), 3392-3403, 2019 | 179 | 2019 |
| Multifactorial central nervous system recurrence susceptibility in patients with HER2‐positive breast cancer: Epidemiological and clinical data from a population‐based cancer … A Musolino, L Ciccolallo, M Panebianco, E Fontana, D Zanoni, C Bozzetti, ... Cancer 117 (9), 1837-1846, 2011 | 150 | 2011 |
| Context matters—consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials E Fontana, K Eason, A Cervantes, R Salazar, A Sadanandam Annals of Oncology 30 (4), 520-527, 2019 | 131 | 2019 |
| Immunogenomics of colorectal cancer response to checkpoint blockade: analysis of the KEYNOTE 177 trial and validation cohorts M Bortolomeazzi, MR Keddar, L Montorsi, A Acha-Sagredo, L Benedetti, ... Gastroenterology 161 (4), 1179-1193, 2021 | 103 | 2021 |
| Early-onset cancer in the gastrointestinal tract is on the rise—evidence and implications I Ben-Aharon, HWM van Laarhoven, E Fontana, R Obermannova, ... Cancer discovery 13 (3), 538-551, 2023 | 83 | 2023 |
| Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study K Khan, M Rata, D Cunningham, DM Koh, N Tunariu, JC Hahne, ... Gut 67 (8), 1484-1492, 2018 | 83 | 2018 |
| Early-onset colorectal adenocarcinoma in the IDEA database: treatment adherence, toxicities, and outcomes with 3 and 6 months of adjuvant fluoropyrimidine and oxaliplatin E Fontana, J Meyers, A Sobrero, T Iveson, AF Shields, J Taieb, T Yoshino, ... Journal of Clinical Oncology 39 (36), 4009-4019, 2021 | 80 | 2021 |
| Novel targets in the treatment of advanced gastric cancer: a perspective review E Fontana, EC Smyth Therapeutic advances in medical oncology 8 (2), 113-125, 2016 | 80 | 2016 |
| Analytical validation of multiplex biomarker assay to stratify colorectal cancer into molecular subtypes C Ragulan, K Eason, E Fontana, G Nyamundanda, N Tarazona, Y Patil, ... Scientific reports 9 (1), 7665, 2019 | 52 | 2019 |
| Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results TA Yap, E Fontana, EK Lee, DR Spigel, M Højgaard, S Lheureux, ... Nature medicine 29 (6), 1400-1411, 2023 | 48 | 2023 |
| Impact of the first Covid-19 pandemic wave on first episode psychosis in Milan, italy. CM Esposito, A D'Agostino, BD Osso, A Fiorentini, C Prunas, A Callari, ... Psychiatry Research 298, 113802, 2021 | 45 | 2021 |
| Recent progress in the systemic treatment of advanced/metastatic cholangiocarcinoma RM Fostea, E Fontana, G Torga, HT Arkenau Cancers 12 (9), 2599, 2020 | 41 | 2020 |
| A seven-Gene Signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial EC Smyth, G Nyamundanda, D Cunningham, E Fontana, C Ragulan, ... Annals of Oncology 29 (12), 2356-2362, 2018 | 39 | 2018 |
| EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers EC Smyth, G Vlachogiannis, S Hedayat, A Harbery, S Hulkki-Wilson, ... Gut 70 (9), 1632-1641, 2021 | 36 | 2021 |
| Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer N Tarazona, F Gimeno-Valiente, V Gambardella, M Huerta, S Rosello, ... ESMO open 5 (5), e000847, 2020 | 32 | 2020 |
| Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer A Wilkins, E Fontana, G Nyamundanda, C Ragulan, Y Patil, D Mansfield, ... Journal for immunotherapy of cancer 9 (3), e001717, 2021 | 25 | 2021 |
| Anti-angiogenic therapies for advanced esophago-gastric cancer E Fontana, F Sclafani, D Cunningham Indian Journal of Medical and Paediatric Oncology 35 (04), 253-262, 2014 | 22 | 2014 |
| MIR21-induced loss of junctional adhesion molecule A promotes activation of oncogenic pathways, progression and metastasis in colorectal cancer A Lampis, JC Hahne, P Gasparini, L Cascione, S Hedayat, ... Cell Death & Differentiation 28 (10), 2970-2982, 2021 | 21 | 2021 |
| Benefit from anti-EGFRs in RAS and BRAF wild-type metastatic transverse colon cancer: a clinical and molecular proof of concept study C Cremolini, M Benelli, E Fontana, F Pagani, D Rossini, G Fucà, A Busico, ... ESMO open 4 (2), e000489, 2019 | 19 | 2019 |
| Characterising timing and pattern of relapse following surgery for localised oesophagogastric adenocarcinoma: a retrospective study SY Moorcraft, E Fontana, D Cunningham, C Peckitt, T Waddell, EC Smyth, ... BMC cancer 16, 1-10, 2016 | 18 | 2016 |